Advertisement

Emergency Department Vancomycin Use: Dosing Practices and Associated Outcomes

Published:December 26, 2012DOI:https://doi.org/10.1016/j.jemermed.2012.09.036

      Abstract

      Background

      Emergency Department (ED) dosing of vancomycin and its effect on outcomes has not been examined.

      Study Objective

      To describe current vancomycin dosing practices for ED patients, focusing on patient factors associated with administration, dosing accuracy based on patient body weight, and clinical outcomes.

      Methods

      Single-center, retrospective cohort study of vancomycin administered in the ED over 18 months in an academic, tertiary care ED. Data were collected on 4656 patients. Data were analyzed using a generalized estimating equations model to account for multiple doses being administered to the same patient.

      Results

      The ED dose was continued, unchanged, in 2560 admitted patients (83.8%). The correct dose was given 980 times (22.1%), 3143 doses (70.7%) were underdosed, and 318 were overdosed (7.2%). Increasing weight was associated with underdosing (adjusted odds ratio 1.52 per 10 kg body weight, p < 0.001). Patients who received doses of vancomycin > 20 mg/kg had longer hospital length of stay (p = 0.005); were more likely to spend ≥ 3 days in the hospital (odds ratio [OR] 1.49; 95% confidence interval [CI] 1.12–1.98, p = 0.006); and more likely to die (OR 1.88; 95% CI 1.22–2.90, p = 0.004).

      Conclusion

      In this largest study to date examining ED vancomycin dosing, vancomycin was commonly given. Dosing outside the recommended range was frequent, and especially prevalent in patients with a higher body weight. The ED dose of vancomycin was frequently continued as an inpatient, regardless of dosing accuracy. There is significant room for improvement in dosing accuracy and indication. Vancomycin dosing in the ED may also affect clinical outcomes.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Norrby S.R.
        • Nord C.E.
        • Finch R.
        • European Society of Clinical Microbiology and Infectious Diseases
        Lack of development of new antimicrobial drugs: a potential serious threat to public health.
        Lancet Infect Dis. 2005; 5: 115-119
        • Achiam C.C.
        • Fernandes C.M.
        • McLeod S.L.
        • et al.
        Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center.
        Eur J Emerg Med. 2012; 18: 2-8
        • May L.
        • Harter K.
        • Yadav K.
        • et al.
        Practice patterns and management strategies for purulent skin and soft-tissue infections in an urban academic ED.
        Am J Emerg Med. 2012; 30: 302-310
        • Odell C.A.
        Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections.
        Curr Opin Pediatr. 2010; 22: 273-277
        • Pallin D.J.
        • Egan D.J.
        • Pelletier A.J.
        • Espinola J.A.
        • Hooper D.C.
        • Camargo Jr., C.A.
        Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.
        Ann Emerg Med. 2008; 51: 291-298
        • Alvarez-Lerma F.
        Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit.
        Intensive Care Med. 1996; 22: 387-394
        • Ibrahim E.H.
        • Sherman G.
        • Ward S.
        • Fraser V.J.
        • Kollef M.H.
        The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.
        Chest. 2000; 118: 146-155
        • Kollef M.H.
        Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.
        Clin Infect Dis. 2000; 31: S131-S138
        • Kumar A.
        • Roberts D.
        • Wood K.E.
        • et al.
        Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.
        Crit Care Med. 2006; 34: 1589-1596
        • Leibovici L.
        • Shraga I.
        • Drucker M.
        • Konigsberger H.
        • Samra Z.
        • Pitlik S.
        The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.
        J Intern Med. 1998; 244: 379-386
        • Lodise T.P.
        • McKinnon P.S.
        • Swiderski L.
        • Rybak M.J.
        Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
        Clin Infect Dis. 2003; 36: 1418-1423
        • Mueller E.W.
        • Hanes S.D.
        • Croce M.A.
        • Wood G.C.
        • Boucher B.A.
        • Fabian T.C.
        Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients.
        J Trauma. 2005; 58: 94-101
        • Rybak M.J.
        • Lomaestro B.M.
        • Rotschafer J.C.
        • et al.
        Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.
        Clin Infect Dis. 2009; 49: 325-327
        • Wright S.
        Appropriateness of vancomycin use in the emergency department.
        Ann Emerg Med. 1998; 32: 531-536
        • Hidayat L.
        High dose vancomycin therapy for MRSA infections efficacy and toxicity.
        Arch Intern Med. 2006; 166: 2138-2144
        • Jeffres M.N.
        • Isakow W.
        • Doherty J.A.
        • et al.
        Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
        Chest. 2006; 130: 947-955
        • Rivers E.
        • Nguyen B.
        • Havstad S.
        • et al.
        • Early Goal-Directed Therapy Collaborative Group
        Early goal-directed therapy in the treatment of severe sepsis and septic shock.
        N Engl J Med. 2001; 345: 1368-1377
        • Duong M.
        • Markwell S.
        • Peter J.
        • Barenkamp S.
        Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient.
        Ann Emerg Med. 2010; 55: 401-407
        • Moran G.
        Methicillin-resistant S. aureus infections among patients in the emergency department.
        N Engl J Med. 2006; 355: 666-674
        • Llera J.L.
        • Levy R.C.
        Treatment of cutaneous abscess: a double-blind clinical study.
        Ann Emerg Med. 1985; 14: 15-19
        • Rajendran P.M.
        • Young D.
        • Maurer T.
        • et al.
        Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.
        Antimicrob Agents Chemother. 2007; 51: 4044-4048
        • Lee M.C.
        • Rios A.M.
        • Aten M.F.
        • et al.
        Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.
        Pediatr Infect Dis J. 2004; 23: 123-127
        • Hasty M.B.
        • Klasner A.
        • Kness S.
        • et al.
        Cutaneous community-associated methicillin-resistant Staphylococcus aureus among all skin and soft-tissue infections in two geographically distant pediatric emergency departments.
        Acad Emerg Med. 2007; 14: 35-40
        • Patanwala A.E.
        • Norris C.J.
        • Nix D.E.
        • Kopp B.J.
        • Erstad B.L.
        Vancomycin dosing for pneumonia in critically ill trauma patients.
        J Trauma. 2009; 67: 802-804
        • Lodise T.P.
        • Patel N.
        • Lomaestro B.M.
        • Rodvold K.A.
        • Drusano G.L.
        Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
        Clin Infect Dis. 2009; 49: 507-514
        • Hazlewood K.A.
        • Brouse S.D.
        • Pitcher W.D.
        • Hall R.G.
        Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?.
        Am J Med. 2010; 123: 182.e1-182.e7
        • Wong-Beringer A.
        • Joo J.
        • Tse E.
        • Beringer P.
        Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.
        Int J Antimicrob Agents. 2011; 37: 95-101
        • Pollack Jr., C.
        • Braunwald E.
        Update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice.
        Ann Emerg Med. 2008; 51: 591-606
      1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
        N Engl J Med. 1995; 333: 1581-1587
        • Kumar A.
        • Roberts D.
        • Wood K.
        • et al.
        Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.
        Crit Care Med. 2006; 34: 1589-1596
        • Wood K.
        Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolsim.
        Chest. 2002; 121: 877-905
        • Boersma E.
        • Maas A.
        • Deckers J.W.
        • et al.
        Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.
        Lancet Infect Dis. 1996; 348: 771-775
        • Blow O.
        • Magliore L.
        • Claridge J.
        • et al.
        The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcomes from major trauma.
        J Trauma. 1999; 47: 964-969
        • Angus D.C.
        • Linde-Zwirble W.T.
        • Lidicker J.
        • Clermont G.
        • Carcillo J.
        • Pinsky M.R.
        Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.
        Crit Care Med. 2001; 29: 1303-1310
        • Solomkin J.S.
        • Mazuski J.E.
        • Bradley J.S.
        • et al.
        Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.
        Surg Infect (Larchmt). 2010; 11: 79-109
        • Daza R.
        • Gutiérrez J.
        • Piédrola G.
        Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections.
        Int J Antimicrob Agents. 2001; 18: 211-215
        • Muder R.R.
        • Brennen C.
        • Rihs J.D.
        • et al.
        Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia.
        Clin Infect Dis. 2006; 42: 46-50